Document is current
Any future updates will be listed below
-
Authors
Noera, Giorgio https://orcid.org/0000-0002-2123-9964
Bertolini, Alfio
Calzà, Laura
Gori, Mercedes
Pitino, Annalisa
D’Arrigo, Graziella
Egan, Colin Gerard
Tripepi, Giovanni
-
Funding
Funding for this research was provided by:
Ministero della Difesa (EF a2011.188., company NCAGE Code AR054)
- License Information
-
More Information
Article History
Received: 1 December 2023
Accepted: 12 July 2024
First Online: 19 August 2024
Declarations
:
: The study was compliant to National Bioethics Committee and Ethics Committee for informed consent due to the urgency of their situation, caused by sudden life-threatening or other sudden serious medical conditions approved under the accordance of Declaration of Helsinki, ICH for pharmaceuticals human drug use and good clinical practice and governmental quality audits (CEAV Prot 1841/2013 I.5/30). Ethics committee approval was granted on 15/04/2013.
: Not applicable.
: GN was executive director of the Stop Shock project and research grant holder from the Italian Ministry of Defence Organization for the scope of dual use drug as public benefit welfare and integration partnership. All other authors are members of the steering group and declare that they have no conflicts of interest.
